The efficacy of triclabendazole (Fasinex) against immature and adult Fasciola hepatica in experimentally infected cattle

Vet Parasitol. 1989 Sep;33(2):117-24. doi: 10.1016/0304-4017(89)90059-9.

Abstract

Eighteen Chinese cattle were experimentally infected with metacercariae of Fasciola hepatica and randomly assigned to 6 groups. Five groups of cattle were treated with a single oral dose of triclabendazole at a dose rate of 12 mg kg-1. At necropsy, the reduction in fluke burden compared with the untreated group was 85, 99.6, 99.8, 100 and 100% for cattle treated 2, 6, 8, 12 and 16 weeks after infection, respectively. Data are also presented on body weight changes during the experimental period and on serum gamma-GT activity in cattle from selected groups. Triclabendazole is considered to be safer and more efficacious than currently available fasciolicides in China.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthelmintics / administration & dosage
  • Anthelmintics / pharmacology
  • Anthelmintics / therapeutic use*
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / pharmacology
  • Benzimidazoles / therapeutic use*
  • Bile Ducts / pathology
  • Cattle
  • Cattle Diseases / drug therapy*
  • Fasciola hepatica / drug effects
  • Fascioliasis / drug therapy
  • Fascioliasis / veterinary*
  • Gallbladder / pathology
  • Liver / pathology
  • Random Allocation
  • Triclabendazole
  • Weight Gain

Substances

  • Anthelmintics
  • Benzimidazoles
  • Triclabendazole